1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Recurrent Anaplastic Ependymoma: new trials by email Literature Review of Recurrent Anaplastic Ependymoma trials Research Report on Recurrent Anaplastic Ependymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer Etoposide, Fludarabine Phosphate, Hematopoietic Cell Transplantation - Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2021-01-14 | 2024-10-26 |
Brain Neoplasms (1) · Choroid Plexus Carcinoma (1) · Ependymoma (1) · Glioma (1) · Medulloblastoma (1) · Neuroectodermal Tumors, Primitive (1) · Rhabdoid Tumor (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1)
Antilymphocyte Serum (1) · Etoposide (1) · Hematopoietic Stem Cell Transplantation (1) · Melphalan (1) · Mycophenolic Acid (1) · Stem Cell Transplantation (1) · Tacrolimus (1) · Thiotepa (1) · fludarabine phosphate (1) · thymoglobulin (1)
M.D. Anderson Cancer Center (1)